This is a prospective, multicenter observational study designed to collect urine and tumor biospecimens and associated clinical data from patients undergoing e…

Bladder CancerUrothelial Carcinoma (UC)Hematuria+1 more

~Estimated

~$10 – $1,050

Convergent Genomics, Inc.NCT07673016

Phase 2

A Phase II Trial of SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma (SUMMIT)

This Phase II clinical trial, titled "A Phase II Trial of Sequential Gemcitabine and Mitomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial…

Urinary Bladder CancerUpper Tract Urothelial CancerUrothelial Cancer

~Estimated

~$10 – $6,250

Rutgers, The State University of New JerseyNCT06822010